Search

MED-EL revolutionises cochlear implantation with unparalleled synchrotron dataset of temporal bones

MED-EL, a leading innovator in the field of cochlear implant research and development, has announced an agreement with the Western University (London, Canada) and Mitacs to gain exclusive access to an extraordinary synchrotron dataset of temporal bones.

Peptest Q&A

Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

Get 20% off your ticket to the Tinnitus Conference 2023

Join Tinnitus UK for their fourth virtual Tinnitus Conference with 20 sessions presenting the latest information and research from world leaders at the forefront of tinnitus and tinnitus support.

A triple threat: showcasing Peptest at three ENT conferences

BIOHIT HealthCare is thrilled to be attending three prestigious otorhinolaryngology conferences over the next few weeks.

UV Smart D60: sustainability in every disinfection cycle

The UV Smart D60 is a CE marked (MDR Class IIa) disinfection device specifically designed for channel-less ENT endoscopes and TEE probes.

HIMSA Rings in the New Year with Lower Noah ES Prices!

HIMSA is happy to announce that due to a successful 2023, we are now able to offer significant price reductions on a Noah ES yearly subscription.